Prevalence and risk factors of depression and anxiety among Chinese adults who received SARS-CoV-2 vaccine - A cross-sectional survey.
J Affect Disord
; 324: 53-60, 2023 03 01.
Article
in English
| MEDLINE | ID: covidwho-2165446
ABSTRACT
BACKGROUND:
Direct data reflecting the psychological problems during the nationwide SARS-CoV-2 vaccination campaign are scarce in China. The aim of this study was to assess the prevalence of depression and anxiety and investigate the associated risk factors after vaccination against SARS-CoV-2 among Chinese adults.METHODS:
We conducted a web-based cross-sectional survey from June to July 2021. A structured questionnaire including the Patient Health Questionnaire-9(PHQ-9) and Generalized Anxiety Disorder-7(GAD-7) was used to investigated depression and anxiety symptoms. After excluding 223 ineligible records, a total of 6984 participants were included in our final analysis. Multivariable logistic regression analysis was used to examined the potential factors associated with depression or anxiety.RESULTS:
Our data indicated that the overall prevalence of depression and anxiety was assessed at 19.39â¯% and 9.74â¯%, respectively. Participants who had vaccinated the second dose were more likely to have depressive symptoms (20.95â¯% vs.16.40â¯%) and anxiety symptoms (10.38â¯% vs. 8.51â¯%) than who had vaccinated the first dose. Multivariable logistic regression analysis indicated female gender, being healthcare worker, college or above and planning a pregnancy were all independently linked to depression or anxiety.LIMITATIONS:
The present study was based on an online survey.CONCLUSION:
The present study confirmed the presence of depression and anxiety among Chinese adults who received SARS-COV-2 vaccine, as well as the potential influencing factors. Additional attention and psychological support should be directed at these high-risk groups during SARS-CoV-2 vaccination campaign.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Country/Region as subject:
Asia
Language:
English
Journal:
J Affect Disord
Year:
2023
Document Type:
Article
Affiliation country:
J.jad.2022.12.077
Similar
MEDLINE
...
LILACS
LIS